{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:15:30Z","timestamp":1790140530106,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1124\/dmd.119.089565","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T15:55:22Z","timestamp":1582300522000},"page":"345-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Theophylline Acetaldehyde as the Initial Product in Doxophylline Metabolism in Human Liver"],"prefix":"10.1016","volume":"48","author":[{"given":"Xiaohua","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiusha","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingkai","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peifang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqing","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyue","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.119.089565_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/03602532.2018.1555587","article-title":"Aldehyde toxicity and metabolism: the role of aldehyde dehydrogenases in detoxification, drug resistance and carcinogenesis","volume":"51","author":"Ahmed Laskar","year":"2019","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.119.089565_bib2","series-title":"Methylxanthines","author":"Bertil","year":"2010"},{"key":"10.1124\/dmd.119.089565_bib3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0090-9556(25)07652-4","article-title":"Doxofylline in rat brain in relation to locomotor activity","volume":"17","author":"Cravanzola","year":"1989","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089565_bib4","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1039\/C6SC03970G","article-title":"A practical strategy to design and develop an isoform-specific fluorescent probe for a target enzyme: CYP1A1 as a case study","volume":"8","author":"Dai","year":"2017","journal-title":"Chem Sci (Camb)"},{"key":"10.1124\/dmd.119.089565_bib5","doi-asserted-by":"crossref","first-page":"14488","DOI":"10.1021\/jacs.5b09854","article-title":"A highly selective ratiometric two-photon fluorescent probe for human cytochrome P450 1A","volume":"137","author":"Dai","year":"2015","journal-title":"J Am Chem Soc"},{"key":"10.1124\/dmd.119.089565_bib6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1185\/030079901750120196","article-title":"Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects","volume":"16","author":"Dini","year":"2001","journal-title":"Curr Med Res Opin"},{"key":"10.1124\/dmd.119.089565_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jpba.2019.05.039","article-title":"Development and validation of a UPLC-MS\/MS method for quantification of doxofylline and its metabolites in human plasma","volume":"174","author":"Fang","year":"2019","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/dmd.119.089565_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/01480549608998237","article-title":"Evaluation of the developmental toxicity of theophylline, dimethyluric acid, and methylxanthine metabolites using Xenopus","volume":"19","author":"Fort","year":"1996","journal-title":"Drug Chem Toxicol"},{"key":"10.1124\/dmd.119.089565_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0090-9556(25)08333-3","article-title":"Metabolism of doxophylline by rat liver microsomes","volume":"14","author":"Grosa","year":"1986","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.089565_bib10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11095-006-9531-2","article-title":"Determination of a human hepatic microsomal scaling factor for predicting in vivo drug clearance","volume":"23","author":"Hakooz","year":"2006","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.119.089565_bib11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2036.1990.tb00512.x","article-title":"The effect of intravenous doxofylline or aminophylline on gastric secretion in duodenal ulcer patients","volume":"4","author":"Lazzaroni","year":"1990","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1124\/dmd.119.089565_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.foodres.2014.05.043","article-title":"Pharmacokinetics of caffeine and its metabolites in plasma and urine after consuming a soluble green\/roasted coffee blend by healthy subjects","volume":"64","author":"Mart\u00ednez-L\u00f3pez","year":"2014","journal-title":"Food Res Int"},{"key":"10.1124\/dmd.119.089565_bib13","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.2147\/COPD.S150887","article-title":"Doxofylline is not just another theophylline!","volume":"12","author":"Matera","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1124\/dmd.119.089565_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ymben.2016.08.003","article-title":"Engineering a microbial platform for de novo biosynthesis of diverse methylxanthines","volume":"38","author":"McKeague","year":"2016","journal-title":"Metab Eng"},{"key":"10.1124\/dmd.119.089565_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/14737167.2017.1301815","article-title":"Treatment plan comparison in acute and chronic respiratory tract diseases: an observational study of doxophylline vs. theophylline","volume":"17","author":"Mennini","year":"2017","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1124\/dmd.119.089565_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/096032719601500603","article-title":"Acute and chronic human toxicity of theophylline","volume":"15","author":"Minton","year":"1996","journal-title":"Hum Exp Toxicol"},{"key":"10.1124\/dmd.119.089565_bib17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1124\/pr.117.014407","article-title":"Interindividual differences in caffeine metabolism and factors driving caffeine consumption","volume":"70","author":"Nehlig","year":"2018","journal-title":"Pharmacol Rev"},{"key":"10.1124\/dmd.119.089565_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/00365519709060032","article-title":"Elimination of theophylline metabolites in healthy adults","volume":"57","author":"Rodopoulos","year":"1997","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1124\/dmd.119.089565_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40248-019-0189-0","article-title":"Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis","volume":"14","author":"Rogliani","year":"2019","journal-title":"Multidiscip Respir Med"},{"key":"10.1124\/dmd.119.089565_bib20","first-page":"98","article-title":"The effects of doxofylline versus theophylline on sleep architecture in COPD patients","volume":"50","author":"Sacco","year":"1995","journal-title":"Monaldi Arch Chest Dis"},{"key":"10.1124\/dmd.119.089565_bib21","first-page":"394","article-title":"Comparative bioavailability of sustained-release and conventional tablets of hydroxyethyltheophylline in man","volume":"17","author":"Sharma","year":"1979","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"10.1124\/dmd.119.089565_bib22","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1517\/14656560903200667","article-title":"Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease","volume":"10","author":"Shukla","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1124\/dmd.119.089565_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/bdd.2510080406","article-title":"Theophylline tissue partitioning and volume of distribution in normal and dietary-induced obese rats","volume":"8","author":"Shum","year":"1987","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.119.089565_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/164_2016_71","article-title":"Xanthines and phosphodiesterase inhibitors","volume":"237","author":"Spina","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/dmd.119.089565_bib25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1248\/yakushi1947.119.11_861","article-title":"Population pharmacokinetic analysis of theophylline: relationship between serum concentrations and clinical effects in therapeutic drug monitoring","volume":"119","author":"Tanikawa","year":"1999","journal-title":"Yakugaku Zasshi"},{"key":"10.1124\/dmd.119.089565_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00003088-199528040-00003","article-title":"Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation","volume":"28","author":"Tr\u00f6ger","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.119.089565_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pupt.2011.10.007","article-title":"The mechanism of action of doxofylline is unrelated to HDAC inhibition, PDE inhibition or adenosine receptor antagonism","volume":"25","author":"van Mastbergen","year":"2012","journal-title":"Pulm Pharmacol Ther"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624077419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624077419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.119.089565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:19:28Z","timestamp":1739956768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624077419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0090955624077419"],"URL":"https:\/\/doi.org\/10.1124\/dmd.119.089565","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Theophylline Acetaldehyde as the Initial Product in Doxophylline Metabolism in Human Liver","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.119.089565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}